They are consistent with the known side effect profile of GLP-1 receptor agonists already approved in the UK (see, for example, the Wegovy Summary of Product Characteristics, available via the electronic Medicines Compendium)
Diagnostics: Peptide-based assays and biomarkers for disease detection
This is the administration rule people often find hardest to follow consistently
Concerns have been raised about serious side effects (e.g., gastrointestinal paralysis)
We will review labs and InBody scans to make sure you are right for the program as well as healthy during your treatment
In small doses, they can cause fever, tiredness and aches, but in large amounts, they can trigger life-threatening conditions like septic shock